A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma

Qing Lan, Richard Cawthon, Min Shen, Stephanie J. Weinstein, Jarmo Virtamo, Unhee Lim, Howard D. Hosgood, Demetrius Albanes, Nathaniel Rothman

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Purpose: Telomere length plays an important role in the maintenance of chromosomal stability and in tumorigenesis. We hypothesized that telomere length in peripheral WBC DNA obtained from healthy individuals would be a predictor of future risk of developing non-Hodgkin lymphoma. Experimental Design: Using a new assay to measure relative telomere length, monochrome multiplex quantitative PCR, which strongly correlates with telomere length measured by Southern blot (Spearman r = 0.91, P < 0.0001) and has high precision (co-efficient of variation = 7%), we compared telomere length in peripheral WBC DNA in 107 incident male non-Hodgkin lymphoma cases and 107 matched controls within the prospective Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study cohort. Results: Median (10th, 90th percentile) telomere length was 1.10 (0.79, 1.43) in cases and 1.02 (0.78, 1.26) in controls (P = 0.0017, Wilcoxon sign test). There was a strong dose-response relationship between quartiles of telomere length and risk of non-Hodgkin lymphoma overall [odds ratios (95% confidence intervals) by quartile: 1.0; 1.1 (0.4-2.7); 1.8 (0.7-4.9); and 3.6 (1.4-8.9); P trend = 0.003], and this association was similar across the most common non-Hodgkin lymphoma subtypes present in this study. Conclusion: These results suggest that longer telomere length may be a potential predictor for future risk of non-Hodgkin lymphoma.

Original languageEnglish (US)
Pages (from-to)7429-7433
Number of pages5
JournalClinical Cancer Research
Volume15
Issue number23
DOIs
StatePublished - Dec 1 2009
Externally publishedYes

Fingerprint

Multiplex Polymerase Chain Reaction
Telomere
Non-Hodgkin's Lymphoma
Prospective Studies
Chromosomal Instability
DNA
beta Carotene
alpha-Tocopherol
Southern Blotting
Carcinogenesis
Cohort Studies
Research Design
Odds Ratio
Maintenance
Confidence Intervals

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. / Lan, Qing; Cawthon, Richard; Shen, Min; Weinstein, Stephanie J.; Virtamo, Jarmo; Lim, Unhee; Hosgood, Howard D.; Albanes, Demetrius; Rothman, Nathaniel.

In: Clinical Cancer Research, Vol. 15, No. 23, 01.12.2009, p. 7429-7433.

Research output: Contribution to journalArticle

Lan, Qing ; Cawthon, Richard ; Shen, Min ; Weinstein, Stephanie J. ; Virtamo, Jarmo ; Lim, Unhee ; Hosgood, Howard D. ; Albanes, Demetrius ; Rothman, Nathaniel. / A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. In: Clinical Cancer Research. 2009 ; Vol. 15, No. 23. pp. 7429-7433.
@article{22f85140e7874578bbea17d775d2821c,
title = "A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma",
abstract = "Purpose: Telomere length plays an important role in the maintenance of chromosomal stability and in tumorigenesis. We hypothesized that telomere length in peripheral WBC DNA obtained from healthy individuals would be a predictor of future risk of developing non-Hodgkin lymphoma. Experimental Design: Using a new assay to measure relative telomere length, monochrome multiplex quantitative PCR, which strongly correlates with telomere length measured by Southern blot (Spearman r = 0.91, P < 0.0001) and has high precision (co-efficient of variation = 7{\%}), we compared telomere length in peripheral WBC DNA in 107 incident male non-Hodgkin lymphoma cases and 107 matched controls within the prospective Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study cohort. Results: Median (10th, 90th percentile) telomere length was 1.10 (0.79, 1.43) in cases and 1.02 (0.78, 1.26) in controls (P = 0.0017, Wilcoxon sign test). There was a strong dose-response relationship between quartiles of telomere length and risk of non-Hodgkin lymphoma overall [odds ratios (95{\%} confidence intervals) by quartile: 1.0; 1.1 (0.4-2.7); 1.8 (0.7-4.9); and 3.6 (1.4-8.9); P trend = 0.003], and this association was similar across the most common non-Hodgkin lymphoma subtypes present in this study. Conclusion: These results suggest that longer telomere length may be a potential predictor for future risk of non-Hodgkin lymphoma.",
author = "Qing Lan and Richard Cawthon and Min Shen and Weinstein, {Stephanie J.} and Jarmo Virtamo and Unhee Lim and Hosgood, {Howard D.} and Demetrius Albanes and Nathaniel Rothman",
year = "2009",
month = "12",
day = "1",
doi = "10.1158/1078-0432.CCR-09-0845",
language = "English (US)",
volume = "15",
pages = "7429--7433",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "23",

}

TY - JOUR

T1 - A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma

AU - Lan, Qing

AU - Cawthon, Richard

AU - Shen, Min

AU - Weinstein, Stephanie J.

AU - Virtamo, Jarmo

AU - Lim, Unhee

AU - Hosgood, Howard D.

AU - Albanes, Demetrius

AU - Rothman, Nathaniel

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Purpose: Telomere length plays an important role in the maintenance of chromosomal stability and in tumorigenesis. We hypothesized that telomere length in peripheral WBC DNA obtained from healthy individuals would be a predictor of future risk of developing non-Hodgkin lymphoma. Experimental Design: Using a new assay to measure relative telomere length, monochrome multiplex quantitative PCR, which strongly correlates with telomere length measured by Southern blot (Spearman r = 0.91, P < 0.0001) and has high precision (co-efficient of variation = 7%), we compared telomere length in peripheral WBC DNA in 107 incident male non-Hodgkin lymphoma cases and 107 matched controls within the prospective Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study cohort. Results: Median (10th, 90th percentile) telomere length was 1.10 (0.79, 1.43) in cases and 1.02 (0.78, 1.26) in controls (P = 0.0017, Wilcoxon sign test). There was a strong dose-response relationship between quartiles of telomere length and risk of non-Hodgkin lymphoma overall [odds ratios (95% confidence intervals) by quartile: 1.0; 1.1 (0.4-2.7); 1.8 (0.7-4.9); and 3.6 (1.4-8.9); P trend = 0.003], and this association was similar across the most common non-Hodgkin lymphoma subtypes present in this study. Conclusion: These results suggest that longer telomere length may be a potential predictor for future risk of non-Hodgkin lymphoma.

AB - Purpose: Telomere length plays an important role in the maintenance of chromosomal stability and in tumorigenesis. We hypothesized that telomere length in peripheral WBC DNA obtained from healthy individuals would be a predictor of future risk of developing non-Hodgkin lymphoma. Experimental Design: Using a new assay to measure relative telomere length, monochrome multiplex quantitative PCR, which strongly correlates with telomere length measured by Southern blot (Spearman r = 0.91, P < 0.0001) and has high precision (co-efficient of variation = 7%), we compared telomere length in peripheral WBC DNA in 107 incident male non-Hodgkin lymphoma cases and 107 matched controls within the prospective Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study cohort. Results: Median (10th, 90th percentile) telomere length was 1.10 (0.79, 1.43) in cases and 1.02 (0.78, 1.26) in controls (P = 0.0017, Wilcoxon sign test). There was a strong dose-response relationship between quartiles of telomere length and risk of non-Hodgkin lymphoma overall [odds ratios (95% confidence intervals) by quartile: 1.0; 1.1 (0.4-2.7); 1.8 (0.7-4.9); and 3.6 (1.4-8.9); P trend = 0.003], and this association was similar across the most common non-Hodgkin lymphoma subtypes present in this study. Conclusion: These results suggest that longer telomere length may be a potential predictor for future risk of non-Hodgkin lymphoma.

UR - http://www.scopus.com/inward/record.url?scp=73149086656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73149086656&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-09-0845

DO - 10.1158/1078-0432.CCR-09-0845

M3 - Article

C2 - 19934287

AN - SCOPUS:73149086656

VL - 15

SP - 7429

EP - 7433

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 23

ER -